Constellation Alpha Capital Corp.
Status: Deal Closed
U=S+W+R
W=S/2@11.5
R=S/10
| IPO Proceeds, $M | $143.75M |
|---|---|
| IPO Date | Jun 20, 2017 |
| CEO | Rajiv Shukla |
| Left Lead | Cowen |
| IPO Cash in Trust | 101.0% |
| SPAC Tenor | 21+6 |
| IPO Sector |
Healthcare
Healthcare Services & Manufacturing in India |
| IPO Geography | Asia |
| Target Company | DermTech |
| Deal Announced | May 29, 2019 |
| Deal Size, $M | $61.60M |
| Deal Sector | Healthcare |
| Deal Geography | US/Canada |
| SEC Filings | www.sec.gov |
| Approval Vote | Aug 27, 2019 |
| Amendment Vote | TBD |
| Closing Date | Aug 29, 2019 |
Formerly CNAC
DMTK
DMTKW
| Price | |
|---|---|
| Volume, 3-month avg. | N/A |
Sign up for Free Trial
No credit card required
Sign in for more on Constellation Alpha Capital Corp.:
- Structure and cap table
- 5 directors & officers
- 13 filings and events
- 3 underwriters
- 1 deal advisors
- 2 legal advisors
Structure
Sign in to view structure, cap table, and calendar of events.
Team
| Name | Age | Title |
|---|---|---|
| Rajiv Shukla | 42 | Chairman & CEO |
| Craig Pollak | 46 | CFO & Secretary |
| Dr. John Alexander | 78 | Director |
| Alan Rosling | 54 | Director |
| Kewal Handa | 58 | Director |
Sign in to view team biographies and more sponsor and affiliate data.
Advisors
Underwriters
| Cowen | BR | 11,000,000 | units |
| Chardan | 1,000,000 | ||
| I-Bankers Securities | 500,000 | ||
| 12,500,000 | units | ||
| Up-Front UW fee | 2.00 | % | |
| Deferred UW fee |
3.50 | % |
Sign in to view more advisor data.
Deal
Sign in to view merger details and deal financials.